Mineralys Therapeutics Inc banner
M

Mineralys Therapeutics Inc
NASDAQ:MLYS

Watchlist Manager
Mineralys Therapeutics Inc
NASDAQ:MLYS
Watchlist
Price: 27.6 USD -0.93% Market Closed
Market Cap: $2.2B

Wall Street
Price Targets

MLYS Price Targets Summary
Mineralys Therapeutics Inc

Wall Street analysts forecast MLYS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MLYS is 52.4 USD with a low forecast of 42.42 USD and a high forecast of 58.8 USD.

Lowest
Price Target
42.42 USD
54% Upside
Average
Price Target
52.4 USD
90% Upside
Highest
Price Target
58.8 USD
113% Upside
Mineralys Therapeutics Inc Competitors:
Price Targets
FLEX
Flex Ltd
19% Upside
VINP
Vinci Partners Investments Ltd
16% Upside
UFPT
UFP Technologies Inc
20% Upside
RCKT
Rocket Pharmaceuticals Inc
140% Upside
GOSS
Gossamer Bio Inc
314% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-61%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-61%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MLYS's stock price target?
Price Target
52.4 USD

According to Wall Street analysts, the average 1-year price target for MLYS is 52.4 USD with a low forecast of 42.42 USD and a high forecast of 58.8 USD.

Back to Top